= BSA &lt

2 trials

Sponsors

Wakayama Medical University, Tohoku Clinical Oncoogy, Research and Education Society(T-CORE)

Conditions

HER2 negative gastric cancerlocally advanced or metastatic unresectable pancreatic cancer and recurrent pancreatic cancer

Phase 1

Phase 1 study of once-daily and alternate-day oral administration of S-1 in patients with locally advanced or metastatic unresectable pancreatic cancer and recurrent pancreatic cancer

Active, not recruitingJPRN-UMIN000006195

Wakayama Medical Universitylocally advanced or metastatic unresectable pancreatic cancer and recurrent pancreatic cancer

Start: 2011-09-01Target: 9Updated: 2026-06-29

Phase 2

PhaseII trial of capecitabine plus cisplatin in patients with recurrent HER-2 negative gastric cancer during or after the adjuvant chemotherapy using S-1 (T-CORE1102)

Active, not recruitingJPRN-UMIN000006804

Tohoku Clinical Oncoogy, Research and Education Society(T-CORE)HER2 negative gastric cancer

Start: 2012-01-01Target: 40Updated: 2026-06-29